7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,810.55

-48.67

-1.70%

4.9270

-0.0620

-1.24%

20.54

+3.34

+19.42%

3,892.10

-139.30

-3.46%

76,781.74

-1,956.66

-2.49%

Crude Oil Dec 26

104.35

+2.35

+2.30%

US Private Equity

10,932.82

-7.68

-0.07%

SES - Delayed Quote SGD

Delfi Limited (P34.SI)

0.6850 +0.0200 (+3.01%)

At close: 5:04:22 PM GMT+8

Loading Chart for P34.SI

Chart Range Bar

Interval:

In partnership with ChartIQ

New Delfi Benchmarking Tool Shows Banks and Credit Unions How Their Bets Measure Against Their Peers’

New Delfi Benchmarking Tool Shows Banks and Credit Unions How Their Bets Measure Against Their Peers’

Delfi Announces Strategic Investment from Members 1st Federal Credit Union to Advance Next-Generation Balance Sheet Management

Delfi Announces Strategic Investment from Members 1st Federal Credit Union to Advance Next-Generation Balance Sheet Management

Delfi Returns to FinovateFall 2026 to Unveil a Pioneering Platform Connecting Balance Sheet Analytics to Execution

Delfi Returns to FinovateFall 2026 to Unveil a Pioneering Platform Connecting Balance Sheet Analytics to Execution

Delfi Appoints Glen Fossella Chief Revenue Officer to Accelerate Go-to-Market Growth

Delfi Appoints Glen Fossella Chief Revenue Officer to Accelerate Go-to-Market Growth

Delfi Joins the Circuit Accelerator Program to Bring Agentic AI to Credit Union Balance Sheets

Delfi Joins the Circuit Accelerator Program to Bring Agentic AI to Credit Union Balance Sheets

DELFI Diagnostics Receives New York State Department of Health Clinical Laboratory Permit, Completing Authorization to Serve Health Systems Across All 50 States

DELFI Diagnostics Receives New York State Department of Health Clinical Laboratory Permit, Completing Authorization to Serve Health Systems Across All 50 States

Some Investors May Be Willing To Look Past Delfi's (SGX:P34) Soft Earnings

Some Investors May Be Willing To Look Past Delfi's (SGX:P34) Soft Earnings

Notice of settlement agreement

Notice of settlement agreement

DELFI Diagnostics Appoints Charles Newton to Board of Directors

DELFI Diagnostics Appoints Charles Newton to Board of Directors

Digital subscription results of AS Ekspress Grupp for the first quarter of 2026

Digital subscription results of AS Ekspress Grupp for the first quarter of 2026

SLB to Expand Digital Portfolio With Strategic Acquisition of Tachyus

SLB to Expand Digital Portfolio With Strategic Acquisition of Tachyus

Mobilize your Website

View Site in Mobile | Classic

Share by: